Leading Cloud Genomics Company DNAnexus Partners With SolveBio to Make Genomic Data More Actionable for Pharmaceutical and Diagnostics Industry
MOUNTAIN VIEW, Calif. & NEW YORK–(BUSINESS WIRE)–DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced a partnership with SolveBio, the global provider of Genomics Intelligence, to integrate the two platforms and provide seamless access to SolveBio’s curated data and analysis services. Researchers globally will have the ability to move quickly from genomic data analysis to interpretation, freeing up time to focus on generating uniquely actionable biological insights.
DNAnexus combines expertise in cloud computing and bioinformatics to provide the global network for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. DNAnexus provides pharmaceutical and biotech companies, global diagnostic test providers, genome centers, and sequencing service providers the infrastructure and scientific support to solve today’s genomic challenges faster and more effectively than ever before.
“Both DNAnexus and SolveBio make genomic data more accessible, easier to analyze, and more actionable,” said Richard Daly, CEO of DNAnexus. “We view the integration of DNAnexus’ and SolveBio’s complementary product offerings as a way help to remove barriers to genomic insight and provide better solutions to enterprises globally.”
SolveBio gathers, secures, and monitors real-time, critical Genomics Intelligence for the pharmaceutical and global diagnostic markets. Access to the latest discoveries and expert assessments in genomics guides key investment decisions in R&D and treatment plans in the clinic. SolveBio turns evaluating and using internal and external insights and information into a standardized task-oriented process for scientists, clinicians, and directors. Integrating with genomic analysis companies allows enterprises leveraging genomics to bring Genomics Intelligence into any workflow or pipeline in a standardized process.
“Our passion is to help scientists make sense of complexity and to use that intelligence to drive issues around human health,” said Mark Kaganovich, CEO of SolveBio. “Our goals are aligned with those of DNAnexus and an integration between our solutions makes a great deal of sense. We look forward to our collective customers being able to seamlessly integrate their analyses with the contextual information that SolveBio provides.”
About DNAnexus
DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomics, operating in North America, Europe, Asia-Pacific (including China), South America, and Africa. The secure, scalable, and collaborative cloud-based DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs globally. For more information, please visit www.dnanexus.com or follow the company @DNAnexus.
About SolveBio
SolveBio deploys technology and on-demand expertise to drive precision medicine. SolveBio’s network of genomics specialists leverages the Genome Intelligence Platform to extract and evaluate complex biomedical data for diagnostic labs, academic centers, and biopharma. By connecting specialists to real-time data, SolveBio helps life science enterprises functionally assess variants and genes with clinical precision. For more information, please visit http://www.solvebio.com or follow the company@Solve.
